Why Valeant Bear Andrew Left Changed Tune on Stock
Shares of Valeant Pharmaceuticals were on the rise again Tuesday after famed short seller Andrew Left had reversed tack on the stock.
Shares of beleaguered Canadian drugmaker Valeant Pharmaceuticals (VRX) were on the rise again Tuesday after Real Money's James Passeri reported that famed short seller Andrew Left had reversed tack on the stock. Previously Left and had warned about the company's pricing problems and looming regulatory issues and was one of the factors behind massive losses in Valeant shares. Passeri explains why Left has changed his tune and what's next on his radar. TheStreet's Jeanne Yurman has details from New York.
